OncoTherapy Science, Inc.

TSE:4564.T

40 (JPY) • At close September 19, 2024
Bedrijfsnaam OncoTherapy Science, Inc.
Symbool 4564.T
Munteenheid JPY
Prijs 40
Beurswaarde 10,865,757,960
Dividendpercentage 0%
52-weken bereik 15 - 64
Industrie Biotechnology
Sector Healthcare
CEO Junichi Shimada
Website https://www.oncotherapy.co.jp

An error occurred while fetching data.

Over OncoTherapy Science, Inc.

OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I

Vergelijkbare Aandelen

Techno Medica Co., Ltd. logo

Techno Medica Co., Ltd.

6678.T

1,935 JPY

MEDINET Co., Ltd. logo

MEDINET Co., Ltd.

2370.T

45 JPY

SEED Co.,Ltd. logo

SEED Co.,Ltd.

7743.T

511 JPY

Medical System Network Co., Ltd. logo

Medical System Network Co., Ltd.

4350.T

440 JPY

Solasia Pharma K.K. logo

Solasia Pharma K.K.

4597.T

49 JPY

JTEC Corporation logo

JTEC Corporation

3446.T

1,563 JPY

Japan Hospice Holdings Inc. logo

Japan Hospice Holdings Inc.

7061.T

1,527 JPY

JMS Co.,Ltd. logo

JMS Co.,Ltd.

7702.T

505 JPY

Carna Biosciences, Inc. logo

Carna Biosciences, Inc.

4572.T

407 JPY

Daiken Medical Co., Ltd. logo

Daiken Medical Co., Ltd.

7775.T

529 JPY

Financiële Gegevens

Cijfers zijn in miljoenen (JPY)

Cijfers zijn in miljoenen (JPY)